AQR Capital Management - AIMMUNE THERAPEUTICS INC ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of AIMMUNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$473,000
+1.1%
17,355
-0.3%
0.00%
Q2 2018$468,000
-15.5%
17,4110.0%0.00%
-100.0%
Q1 2018$554,000
+15.2%
17,411
+37.0%
0.00%0.0%
Q4 2017$481,000
-34.6%
12,713
-57.2%
0.00%0.0%
Q3 2017$736,000
+153.8%
29,678
+110.5%
0.00%
Q2 2017$290,00014,0960.00%
Other shareholders
AIMMUNE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TLP GROUP LLC 2,904,185$43,563,00046.00%
Foresite Capital Management II, LLC 3,967,900$59,519,00028.42%
Aisling Capital LLC 2,990,000$44,850,0009.24%
Foresite Capital Management III, LLC 935,020$14,025,0006.56%
Vivo Capital, LLC 763,009$11,445,0003.57%
RA Capital Management 1,292,940$19,394,0002.00%
Palo Alto Investors LP 379,727$5,696,0000.33%
EMERALD MUTUAL FUND ADVISERS TRUST 418,214$6,273,0000.32%
EMERALD ADVISERS, LLC 464,364$6,965,0000.31%
Rock Springs Capital Management LP 293,000$4,395,0000.28%
View complete list of AIMMUNE THERAPEUTICS INC shareholders